ONCOLOGÍA PEDIÁTRICA
Hospital Virgen de la Arrixaca
Murcia, EspañaPublicaciones en colaboración con investigadores/as de Hospital Virgen de la Arrixaca (12)
2024
-
GEDEFO-SEFH management of antineoplastic extravasations survey results
Journal of Oncology Pharmacy Practice, Vol. 30, Núm. 1, pp. 67-77
-
MYC-rearranged mature B-cell lymphomas in children and young adults are molecularly Burkitt Lymphoma
Blood Cancer Journal, Vol. 14, Núm. 1
2023
2022
-
Antineoplastic extravasation management: Consensus of the Spanish Oncology Pharmacy Group (GEDEFO)
Journal of Oncology Pharmacy Practice, Vol. 28, Núm. 5, pp. 1170-1181
-
Clinical spectrum of COVID-19 and risk factors associated with severity in Spanish children
European journal of pediatrics, Vol. 181, Núm. 3, pp. 1105-1115
-
Diverse mutations and structural variations contribute to Notch signaling deregulation in paediatric T-cell lymphoblastic lymphoma
Pediatric Blood and Cancer, Vol. 69, Núm. 11
2021
-
Classification of antineoplastic drug-induced tissue damage: a Consensus of the Spanish Oncology Pharmacy Group
Farmacia Hospitalaria, Vol. 45, Núm. 4, pp. 198-203
2020
-
Initial report on Spanish pediatric oncologic, hematologic, and post stem cell transplantation patients during SARS-CoV-2 pandemic
Pediatric Blood and Cancer
-
Optimised molecular genetic diagnostics of Fanconi anaemia by whole exome sequencing and functional studies
Journal of Medical Genetics, Vol. 57, Núm. 4, pp. 258-268
2019
-
ECLIM-SEHOP, a new platform to set up and develop international academic clinical trials for childhood cancer and blood disorders in Spain
Clinical and Translational Oncology, Vol. 21, Núm. 12, pp. 1763-1770
-
Quantification of urinary derivatives of Phenylbutyric and Benzoic acids by LC-MS/MS as treatment compliance biomarkers in Urea Cycle disorders
Journal of pharmaceutical and biomedical analysis, Vol. 176, pp. 112798
2013
-
Actualización del tratamiento con L-asparraginasa en Pediatría
Anales de Pediatria, Vol. 79, Núm. 5